Literature DB >> 20696313

The impact of genetic research on our understanding of Parkinson's disease.

Ian Martin1, Valina L Dawson, Ted M Dawson.   

Abstract

Until recently, genetics was thought to play a minor role in the development of Parkinson's disease (PD). Over the last decade, a number of genes that definitively cause PD have been identified, which has led to the generation of disease models based on pathogenic gene variants that recapitulate many features of the disease. These genetic studies have provided novel insight into potential mechanisms underlying the aetiology of PD. This chapter will provide a profile of the genes conclusively linked to PD and will outline the mechanisms of PD pathogenesis implicated by genetic studies. Mitochondrial dysfunction, oxidative stress and impaired ubiquitin-proteasome system function are disease mechanisms that are particularly well supported by genetic studies and are therefore the focus of this chapter. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696313      PMCID: PMC4451604          DOI: 10.1016/S0079-6123(10)83002-X

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  168 in total

1.  The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.

Authors:  Alexander Zimprich; Bertram Müller-Myhsok; Matthew Farrer; Petra Leitner; Manu Sharma; Mary Hulihan; Paul Lockhart; Audrey Strongosky; Jennifer Kachergus; Donald B Calne; Jon Stoessl; Ryan J Uitti; Ronald F Pfeiffer; Claudia Trenkwalder; Nikolaus Homann; Erwin Ott; Karoline Wenzel; Friedrich Asmus; John Hardy; Zbigniew Wszolek; Thomas Gasser
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

Review 2.  The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.

Authors:  K K Chung; V L Dawson; T M Dawson
Journal:  Trends Neurosci       Date:  2001-11       Impact factor: 13.837

3.  Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.

Authors:  Hans-Hermann Hoepken; Suzana Gispert; Blas Morales; Oliver Wingerter; Domenico Del Turco; Alexander Mülsch; Robert L Nussbaum; Klaus Müller; Stefan Dröse; Ulrich Brandt; Thomas Deller; Brunhilde Wirth; Alexei P Kudin; Wolfram S Kunz; Georg Auburger
Journal:  Neurobiol Dis       Date:  2006-11-30       Impact factor: 5.996

Review 4.  Parkin blushed by PINK1.

Authors:  Jeanne M M Tan; Ted M Dawson
Journal:  Neuron       Date:  2006-05-18       Impact factor: 17.173

5.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein.

Authors:  Amy B Manning-Bog; Alison L McCormack; Jie Li; Vladimir N Uversky; Anthony L Fink; Donato A Di Monte
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

6.  DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase.

Authors:  Eva Andres-Mateos; Celine Perier; Li Zhang; Beatrice Blanchard-Fillion; Todd M Greco; Bobby Thomas; Han Seok Ko; Masayuki Sasaki; Harry Ischiropoulos; Serge Przedborski; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

7.  Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases.

Authors:  David S Goldstein; LaToya Sewell
Journal:  Parkinsonism Relat Disord       Date:  2009-02-07       Impact factor: 4.891

8.  The PINK1/Parkin pathway regulates mitochondrial morphology.

Authors:  Angela C Poole; Ruth E Thomas; Laurie A Andrews; Heidi M McBride; Alexander J Whitworth; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

Review 9.  Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.

Authors:  Elisa Greggio; Mark R Cookson
Journal:  ASN Neuro       Date:  2009-04-14       Impact factor: 4.146

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  16 in total

1.  Association between Parkinson's disease and G2019S and R1441C mutations of the LRRK2 gene.

Authors:  Xiao-Xia Li; Qin Liao; Huan Xia; Xin-Ling Yang
Journal:  Exp Ther Med       Date:  2015-07-27       Impact factor: 2.447

Review 2.  Animal models of human genetic diseases: do they need to be faithful to be useful?

Authors:  Jean-Louis Guénet
Journal:  Mol Genet Genomics       Date:  2011-05-06       Impact factor: 3.291

Review 3.  A guide to neurotoxic animal models of Parkinson's disease.

Authors:  Kim Tieu
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

4.  Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.

Authors:  M Angela Cenci; Christine Konradi
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

5.  Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.

Authors:  Laura M Grant; Franziska Richter; Julie E Miller; Stephanie A White; Cynthia M Fox; Chunni Zhu; Marie-Francoise Chesselet; Michelle R Ciucci
Journal:  Behav Neurosci       Date:  2014-04       Impact factor: 1.912

Review 6.  Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

Authors:  Erika Guerrero; P Vasudevaraju; Muralidhar L Hegde; G B Britton; K S Rao
Journal:  Mol Neurobiol       Date:  2012-08-26       Impact factor: 5.590

7.  Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse.

Authors:  Brian P Dranka; Alison Gifford; Anamitra Ghosh; Jacek Zielonka; Joy Joseph; Anumantha G Kanthasamy; Balaraman Kalyanaraman
Journal:  Neurosci Lett       Date:  2013-05-28       Impact factor: 3.046

8.  Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.

Authors:  Zhaohui Liu; Shusei Hamamichi; Byoung Dae Lee; Dejun Yang; Arpita Ray; Guy A Caldwell; Kim A Caldwell; Ted M Dawson; Wanli W Smith; Valina L Dawson
Journal:  Hum Mol Genet       Date:  2011-07-18       Impact factor: 5.121

9.  The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease.

Authors:  Eleftheria K Pissadaki; J Paul Bolam
Journal:  Front Comput Neurosci       Date:  2013-03-18       Impact factor: 2.380

10.  Living on the edge with too many mouths to feed: why dopamine neurons die.

Authors:  J Paul Bolam; Eleftheria K Pissadaki
Journal:  Mov Disord       Date:  2012-09-24       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.